U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820917) titled 'Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis' on Sept. 09.

Brief Summary: This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression.

Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Cirrhosis

Intervention: DEVICE: Transcutaneous Electrical Acustimulation (TEA)

Participant will apply TEA at home twice a day (approximately 45 minutes am/pm) for 8 weeks. The top electrode ...